1. Home
  2. TSBK vs CHRS Comparison

TSBK vs CHRS Comparison

Compare TSBK & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Timberland Bancorp Inc.

TSBK

Timberland Bancorp Inc.

SELL

Current Price

$37.42

Market Cap

306.8M

Sector

Finance

ML Signal

SELL

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

HOLD

Current Price

$1.63

Market Cap

291.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSBK
CHRS
Founded
1915
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
306.8M
291.5M
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
TSBK
CHRS
Price
$37.42
$1.63
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.51
AVG Volume (30 Days)
16.3K
1.8M
Earning Date
04-28-2026
06-01-2026
Dividend Yield
3.03%
N/A
EPS Growth
21.93
472.00
EPS
1.04
1.43
Revenue
N/A
N/A
Revenue This Year
N/A
$88.67
Revenue Next Year
N/A
$28.64
P/E Ratio
$36.80
$1.18
Revenue Growth
N/A
N/A
52 Week Low
$27.51
$0.72
52 Week High
$40.41
$2.62

Technical Indicators

Market Signals
Indicator
TSBK
CHRS
Relative Strength Index (RSI) 45.80 41.81
Support Level $37.74 $1.55
Resistance Level $38.18 $1.75
Average True Range (ATR) 0.87 0.11
MACD -0.14 -0.00
Stochastic Oscillator 25.31 12.79

Price Performance

Historical Comparison
TSBK
CHRS

About TSBK Timberland Bancorp Inc.

Timberland Bancorp Inc is a bank holding company for Timberland Bank. The bank offers banking services including personal checking and savings accounts, debit cards, health savings accounts, online and mobile banking, online bill pay, 24-hour phone banking, and Zelle. Business services include business checking accounts, online banking, remote deposit, ACH transactions, Autobooks, and insured cash sweep services. The bank also provides lending services such as personal credit cards, home loans, home equity borrowing, construction loans, and SBA loans. In addition, it offers loans to real estate, including residential and commercial real estate, multi-family construction loans, one- to four-family residential loans, multi-family loans, commercial real estate loans, and land loans.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.

Share on Social Networks: